Filing Details
- Accession Number:
- 0001209191-19-061469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-20 12:54:18
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2019-12-20 12:54:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1262104 | Mei Pharma Inc. | MEIP | Pharmaceutical Preparations (2834) | 510407811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1288233 | Phd P Daniel Gold | C/O Mei Pharma, Inc. 3611 Valley Centre Drive, Suite 500 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-19 | 18,750 | $1.60 | 361,632 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
